Volume 53, Issue 3, Pages 547-553 (March 2008) PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate Cancer Roman Ganzer, Sebastian Rogenhofer, Bernhard Walter, Jens-Claudio Lunz, Martin Schostak, Wolf F. Wieland, Andreas Blana European Urology Volume 53, Issue 3, Pages 547-553 (March 2008) DOI: 10.1016/j.eururo.2007.07.010 Copyright © 2007 European Association of Urology Terms and Conditions
Fig. 1 Actuarial disease–free survival rates for three prostate-specific antigen nadir groups defined by the new American Society of Therapeutic Radiology and Oncology criteria. European Urology 2008 53, 547-553DOI: (10.1016/j.eururo.2007.07.010) Copyright © 2007 European Association of Urology Terms and Conditions